Veradermics, Incorporated Common Stock (MANE)
R&D Expense Growth
166.57%
Fiscal year · Period ending:
MANE R&D Expense Growth
Latest reported166.57%period ending
Latest reported166.57%period ending
MANE FY R&D Growth (YoY) (0.00% → 166.57%)
Latest values, visible window
High-resolution chart · PNG
MANE r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 166.5679% | |
| 55.5207% | |
| 0% |